Concepedia

Author

Pratap Neelakantan

Royal Berkshire NHS Foundation Trust

Also Known As

Neelakantan, Pratap, P. Neelakantan, Pratap Neelakantan

30

Publications

292

Citations

8

H-Index

25

Concepts

All Affiliations

Royal Berkshire NHS Foundation TrustImperial College LondonHammersmith HospitalCambridge University Hospitals NHS Foundation TrustUniversity of Liverpool
PN

About

Pratap Neelakantan is an author at Royal Berkshire NHS Foundation Trust specializing in immunology, medicine, and platelet activation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

59

2

Immunology

2

2

59

3

Pathology

1

1

37

4

Pharmacology

1

1

37

5

Chronic Inflammation

1

1

22

Pratap Neelakantan

×

8

Publications

258

Citations

8

H-Index

YearCitations

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies

Pratap Neelakantan, Gareth Gerrard, Claire Lucas,

Blood

2013

93

Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

Pratap Neelakantan, David Marín, Michael Laffan,

Haematologica

2012

37

Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study

Dragana Milojković, Nicholas C.P. Cross, Sahra Ali,

British Journal of Haematology

2020

29

Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy

Stephen Booth, John Willan, Dalia Khan,

European Journal Of Haematology

2020

28

Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma

David Austin, Rebecca Maier, Nasima Akhter,

JACC CardioOncology

2024

26

Combined IL‐6 and JAK/STAT inhibition therapy in COVID‐19‐related sHLH, potential game changer

Sophie Portsmore, Thien Ngoc Nguyen, Emma Beacham,

British Journal of Haematology

2020

22

The management of myelofibrosis: A British Society for Haematology Guideline

Donal P. McLornan, Bethan Psaila, Joanne Ewing,

British Journal of Haematology

2023

13

Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm

Richard Anthony Salisbury, Natalia Curto‐García, Jennifer O’Sullivan,

Leukemia

2021

10

Page 1